In today’s world, where we are all bombarded with various platforms and instrumentations, how do you decide which platform to go with in support of your project? Afshin Safavi, Ph.D., of BioAgilytix, offers his expert opinion in this Virtual Podium presentation.
Dr. Safavi is a veteran biochemist with extensive experience establishing and leading bioanalytical teams in pharmaceutical, biotechnology, and manufacturing companies, as well as contract research organizations. He and his teams have supported the development of a broad range of therapeutics in preclinical and clinical trial laboratories. Prior to founding BioAgilytix Labs, he was the Director of Ligand Binding and Immunoassay, operating under GLP at AAIPharma.